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MicroRNAs are small molecules, found in all cell types and body fluids, which most commonly affect negatively 
to gene expressions by translational repression. Their role in various physiological conditions and diseases has 
been emphasized during the last twenty years. In our recent studies with postmenopausal monozygotic twin 
sisters (n=11), we have investigated how different systemic hormonal status affects the levels of specific 
circulating microRNAs and other molecules related to inflammation and apoptosis, both processes associated 
with aging. Our results have shown that the systemic levels of miR-21, miR-146a and Fas ligand are lower within 
the postmenopausal women who are using estrogen-based hormonal replacement (HRT), compared to their 
non-using co-twins (p=0.018, p=0.039, p=0.021, respectively). To get further knowledge about the aging effect, we 
also measured the same markers from the premenopausal control women (n=8), with natural hormonal status, 
and found out that the inflammatory profile was healthier among the young women and that the serum miR-21 
profile was more similar with the HRT users than non-users, and miR-146 and FasL profile more similar to 
non-users. These findings demonstrate that HRT has effects on the circulating inflammation related regulatory 
molecules. Whether we can state that the effects are clearly positive or negative, needs further investigations and 
understanding of the regulatory system. 
To cite this article: R.Kangas, et al. Aging and systemic hormonal status affects the circulating miR-21, miR-146a and FasL 
levels. RNA Dis 2015; 2: e552. doi: 10.14800/rd.552. 
Aging is a process influenced by the combination of 
genetics and environmental factors. During the last decades, 
epigenetics, including microRNA (miR) regulation, has 
revolutionized our understanding of how our genes are being 
switched on and off. It is known that a single miR can 
regulate several biological processes as well as a group of 
miRs are affecting the expression of a single gene. To make 
it more complex, it is not only about how miRs regulate 
different processes: In addition, also miRs themselves are 
regulated by various molecules such as sex steroid hormones. 
Interest towards the interplay between hormonal regulation 
and different stages of miR maturation and targeting has 
emerged among many research groups in the recent years[1]. 
The studies have shown that the regulatory system among 
these molecules is bi-directional, meaning both hormonal 
signaling and miR biogenesis and function are affecting each 
other. It has also been stated that miRs deliver their messages 
similarly to hormones themselves. In our recent study we 
demonstrated that circulating miR-21 (onco-miR) and 
miR-146a (inflamma-miR) levels differ between 
postmenopausal monozygotic twin sisters whose hormonal 
status differs from each other, especially what comes to 
systemic estrogen concentrations[2]. We have also shown 
with the same data, that HRT enhances the IGF-1 signaling 
by lowering the levels of miR-223 and miR-182 in the 
skeletal muscle[3]. In addition, we have reported that the HRT 
users possess better muscle quality properties than the 
non-user twin sisters[4]. Nothnick et al[5] have also studied the 
interplay of hormones and miR regulation within the uterus 
of ovariectomized mice by demonstrating that steroid 
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hormones not only affect the miR expression at the 
transcription level but also the expression of the molecules, 
Exportin-5 and Dicer1,involved in miR maturation process. 
Several studies are focusing on the associations with miR 
levels and cancers associated with tissues sensitive to 
estrogens and androgens [6-8]. 
One of the most intriguing questions in miR research is 
whether we should consider a change in a single miR level 
significant or should we examine the miR profile from a 
specific tissue as a whole. Many studies have shown that 
changes in specific miR levels are characteristics to certain 
diseases such as various cancers, autoimmune disorders and 
neurological diseases[9]. Another set of studies has shown 
changes in miR profiles in different conditions[10]. As we 
showed in our recent twin paper, the levels of specific 
circulating miRs are partly genetically regulated (miR-21: 
r=0.66, miR-146a: r=0.38)[2]. Due to that, setting common 
reference values for normal and abnormal miR levels for the 
clinical use, might be challenging.  
In our ongoing studies we are focusing on the serum levels 
of the specific miRs and FasL in another longitudinal data set 
consisting of aged male sprint athletes[11]. It seems like an 
aging effect can be detected in this unique study population 
what comes to the studied molecules. In addition, our miR 
work continues with the already discussed twin data, in order 
to get a better picture of the entire miR profile of the serum 
samples.  
Overall, it is not so obvious, whether we express certain 
inherited properties or not, it is all about the interplay 
between the genes and the environment and the bunch of 
molecules working in between. MicroRNAs seem to be one 
of the sensitive mechanisms affecting the fine-tuning of the 
gene expression. Due to their already detected variation in 
different conditions and diseases and high stability in the 
biological samples, miRs are promising tools to be used in 
diagnostics and therapeutics. However, in order to generalize 
and take the miR analysis into official clinical use, the 
methods need to be standardized. 
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